All Type of News


It costs KRW 200 million to purchase hepatitis C medicines for full recover

As new drugs came out for hepatitis B and hepatitis C, which are the main factors of liver diseases, such as cirrhosis and live cancer, patients can enjoy effects of the treatments helping them recover completely. Un...

Controversy with Healthcare Commercialization, tobacco price increases, and the hardly mentioned issues about the pharm industry in the national inspection for Ministry of Health and Welfare

At the national inspection for Ministry of Health and Welfare on November 13 and 14, the healthcare industry was denounced in regards to tobacco price rises, various welfare p...

The ‘Usage-Medicine Price Linkage system’, interrupting overseas expansion of new medicines, such as Kanarb and Noltec

Since the Usage-Medicine Price Linkage system gets in the way of overseas expansion of new medicines, comments about preparing countermeasures for the issue brought up at the national inspection. The Usage-Medicine P...

Will blockbusters of the pharmaceutical industry breathe life into the generic market?

The new generic market estimated at KRW 350 billion will be opened next year. According to the 2015 Pharmaceutical Bio Industry Prospect Report, published by Shinhan Investment Corporation on the 13th, it was anticip...

Entering to the U.S. market will be visualize as 10 companies are undergoing challenges to get FDA’s approvals

Korean pharmaceutical companies will hit stride in their global challenges targeting the U.S. market. As the impotency drug that Mezzion, a new drug development company, made partnership with Actavis is expected to b...

Based on the winning against GSK, the pharmaceutical distribution industry is on the way to put pressure on other multinational companies

The pharmaceutical distribution industry is on a positive streak after the distribution cost war against GSK. According to the pharmaceutical industry, several multinational ph...

Seriousness of a new type of illegal rebates provided by CSO

Although the government has enforced various regulations to eradicate illegal rebates for medicines, it was indicated that the third illegal rebate, called Contract Sales Organization (hereinafter referring to CSO), i...

The flu vaccine of Green Cross will exceed yearly sales in excess of KRW 100 billion

Since Green Cross produced the first influenza vaccine five years ago at the Hwasoon factory in Jeollanam-do in 2009 as the very first domestic pharmaceutical company, it has passed producing 100 million doses of infl...

Market shares of clinics’ medical expenses has been ‘falling down’

It was shown that market shares of clinics’ medical expenses has decreased for the past 10 years, and particularly the size of clinics’ outpatients medical expenses has been diminished. According to the analysis resu...

The pharmaceutical industry is no longer available to operate rebate businesses

“Rebate sales marketing is no longer available in the pharmaceutical industry. This is because making funds for rebates is not an option anymore.” The statement was quoted by a CEO of a medium-sized pharmaceutical com...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.